Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1981 1
1983 1
1984 1
1986 1
1989 1
1992 2
1993 1
1994 2
1995 5
1996 5
1997 6
1998 10
1999 6
2000 9
2001 13
2002 12
2003 9
2004 14
2005 4
2006 15
2007 15
2008 11
2009 17
2010 16
2011 19
2012 15
2013 13
2014 11
2015 22
2016 22
2017 35
2018 26
2019 17
2020 26
2021 28
2022 16
Text availability
Article attribute
Article type
Publication date

Search Results

375 results
Results by year
Filters applied: . Clear all
Page 1
Augmentation des complications sanitaires graves lors de l’usage non-médical du protoxyde d’azote en France.
Association française des centres d’addictovigilance, Micallef J, Mallaret M, Lapeyre-Mestre M, Daveluy A, Victorri-Vigneau C, Peyrière H, Debruyne D, Deheul S, Bordet R, Chevallier C, Perault-Pochat MC, Le Boisselier R, Libert F, Chaouachi L, Gillet P. Association française des centres d’addictovigilance, et al. Among authors: micallef j. Therapie. 2021 Jan-Feb;76(1):53-54. doi: 10.1016/j.therap.2020.01.001. Epub 2020 Jan 17. Therapie. 2021. PMID: 32005483 French. No abstract available.
Atypical thrombosis associated with VaxZevria® (AstraZeneca) vaccine: Data from the French Network of Regional Pharmacovigilance Centres.
Gras-Champel V, Liabeuf S, Baud M, Albucher JF, Benkebil M, Boulay C, Bron A, El Kaddissi A, Gautier S, Geeraerts T, Girot M, Grandvuillemin A, Laujin H, Jonville-Béra AP, Masmoudi K, Massardier E, Micallef J, Mounier C, Montastruc F, Pariente A, Perez J, Raposo N, Salvo F, Valnet-Rabier MB, Vial T, Massy N; French Network of Pharmacovigilance Centres. Gras-Champel V, et al. Among authors: micallef j. Therapie. 2021 Jul-Aug;76(4):369-373. doi: 10.1016/j.therap.2021.05.007. Epub 2021 May 19. Therapie. 2021. PMID: 34083026 Free PMC article. No abstract available.
Prévention des risques liés à un usage inapproprié/consommation inutile des médicaments.
Cracowski JL, Muller S, Anglade I, Bonnefond G, Bouhanick B, Bouquet S, Cabut S, Daynès P, Denis B, Durand D, Jonville-Béra AP, Lahouegue A, Léo M, Micallef J, Molimard M, Penfornis C, Querol-Ferrer V. Cracowski JL, et al. Among authors: micallef j. Therapie. 2022 Jan-Feb;77(1):69-78. doi: 10.1016/j.therap.2021.12.020. Epub 2022 Jan 4. Therapie. 2022. PMID: 35067334 French. No abstract available.
Drugs and orphan diseases.
Blin O, Micallef J. Blin O, et al. Among authors: micallef j. Therapie. 2020 Apr;75(2):131-132. doi: 10.1016/j.therap.2020.02.002. Epub 2020 Feb 13. Therapie. 2020. PMID: 32247679 No abstract available.
How to strengthen the presence of patients in health technology assessments conducted by the health authorities.
Mamzer MF, Dubois S, Saout C; participants of Round Table «Topical Subject» of Giens XXXIII, Albin N, Béhier JM, Buisson A, Diebolt V, Delaitre O, Duguet C, Fagon JY, Gaillard S, Le Jeunne C, Mazars R, Micallef J, Nabarette H, Piazza L, Raynaud C, Varoqueaux N. Mamzer MF, et al. Among authors: micallef j. Therapie. 2018 Feb;73(1):95-105. doi: 10.1016/j.therap.2017.11.004. Epub 2017 Dec 21. Therapie. 2018. PMID: 29478707 French.
Orphan drug clinical development.
Blin O, Lefebvre MN, Rascol O, Micallef J. Blin O, et al. Among authors: micallef j. Therapie. 2020 Apr;75(2):141-147. doi: 10.1016/j.therap.2020.02.004. Epub 2020 Feb 13. Therapie. 2020. PMID: 32247678 Review.
375 results